Real-world Evidence from a Retrospective Multicentre Analysis on First-line Therapy for Metastatic Papillary Renal Cell Carcinoma. A GUARDIANS Project

Background and objective: Papillary renal cell carcinoma (pRCC) is a rare disease. The optimal treatment of metastatic pRCC is still unclear. We evaluated real-world treatment outcomes of first-line treatment in this cohort in Germany. Methods: Patients with advanced or metastatic pRCC were eligible...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Thomas Hilser, Jozefina Casuscelli, Can Aydogdu, Stefanie Zschäbitz, Marco Julius Schnabel, Emily Rinderknecht, Angelika Mattigk, Martin Schostak, Anna-Lisa Volk, Philipp Ivanyi, Jonas Wiegmann, Christopher Darr, Luka Flegar, Subhajit Mandal, Katrin Schlack, Daniel Seidl, Analena Handke, Melanie Klee, Tim Nestler, Marc Rehlinghaus, Sameh Hijazi, Axel Heidenreich, Viktor Grünwald, Pia Paffenholz
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Elsevier 2025-08-01
Reeks:	European Urology Open Science
Onderwerpen:	Papillary renal cell cancer Immune checkpoint inhibitor Tyrosine kinase inhibitor First-line treatment
Online toegang:	http://www.sciencedirect.com/science/article/pii/S2666168325002447
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!